P3 Health Partners Inc. (PIIIW)
NASDAQ: PIIIW
· Real-Time Price · USD
0.01
0.00 (13.64%)
At close: May 12, 2025, 12:14 PM
P3 Health Partners Revenue Breakdown
Period Ending | Dec 31, 2024 | Dec 31, 2022 |
---|---|---|
Capitated Revenue Revenue | 1.48B | 1.03B |
Capitated Revenue Revenue Growth | +43.37% | n/a |
Health Care, Patient Service Revenue | 16.85M | 14.67M |
Health Care, Patient Service Revenue Growth | +14.87% | n/a |
Operating Expense Breakdown
Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 31.83M | 27.35M | 27.02M | 27.72M | 25.15M | 33.72M | 28.08M | 38.64M | 41.4M | 38.98M | 42.51M | 39.46M | 54.84B | 20.92M | 18.75M | 15.33M | 17.49M | 14.02M | 11.92M | 11.46M |
Selling, General, and Administrative Revenue Growth | +16.36% | +1.22% | -2.52% | +10.22% | -25.41% | +20.08% | -27.34% | -6.66% | +6.20% | -8.29% | +7.71% | -99.93% | +261969.71% | +11.62% | +22.30% | -12.35% | +24.72% | +17.65% | +3.96% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales and Marketing Revenue | 461K | 134K | 414K | 322K | 721K | 654K | 857K | 1M | 1.7M | 1.12M | 1.41M | 864.53K | 1.5B | 491.42K | 356.5K | 270.24K | 871.56K | 278.66K | 149.13K | 203.28K |
Sales and Marketing Revenue Growth | +244.03% | -67.63% | +28.57% | -55.34% | +10.24% | -23.69% | -14.39% | -41.12% | +51.85% | -20.49% | +62.87% | -99.94% | +305447.59% | +37.84% | +31.92% | -68.99% | +212.77% | +86.86% | -26.64% | n/a |